Carson Wealth (CWM LLC)’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$56.3K Buy
1,015
+4
+0.4% +$215 ﹤0.01% 3728
2025
Q4
$49K Buy
1,011
+2
+0.2% +$78 ﹤0.01% 3612
2025
Q3
$31K Sell
1,009
-127
-11% -$2.92K ﹤0.01% 3853
2025
Q2
$25K Buy
1,136
+307
+37% +$6.43K ﹤0.01% 3764
2025
Q1
$15K Buy
829
+791
+2,082% +$13.2K ﹤0.01% 3857
2024
Q4
$1K Sell
38
-97
-72% -$2.35K ﹤0.01% 4648
2024
Q3
$5K Buy
135
+99
+275% +$3.38K ﹤0.01% 4060
2024
Q2
$1K Buy
36
+5
+16% +$116 ﹤0.01% 4300
2024
Q1
$1K Buy
31
+12
+63% +$284 ﹤0.01% 4063
2023
Q4
$0 Buy
+19
New +$328 ﹤0.01% 4106
2023
Q2
Sell
-20
Closed 4153
2023
Q1
$0 Buy
+20
New +$486 ﹤0.01% 4020

Other funds holding ANAB

Carson Wealth (CWM LLC)'s ANAB Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its AnaptysBio (ANAB) stake by 0.4% in Q1 2026, buying an estimated $215 and bringing the position to 1,015 shares worth $56.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3728.

Carson Wealth (CWM LLC) first reported a position in ANAB in Q1 2023 and has held it in 11 quarters since. 207 funds tracked by Wall St. Rank hold ANAB as of Q1 2026.

  • Carson Wealth (CWM LLC) held 1,015 shares of AnaptysBio worth $56.3K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 4 AnaptysBio shares in Q1 2026, an estimated $215.
  • AnaptysBio made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #3728 holding.
  • Carson Wealth (CWM LLC) first reported a position in AnaptysBio in Q1 2023 and has held it in 11 quarters since.
  • 207 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.